Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR‐α/sirtuin 1/PGC‐1α pathway
British Journal of Pharmacology2016Vol. 173(6), pp. 1095–1109
Citations Over TimeTop 10% of 2016 papers
Guangzhong Liu, Tingting Hou, Yue Yuan, Pengzhou Hang, Jingjing Zhao, Li Sun, Guanqi Zhao, Jing Zhao, Jingmei Dong, Xiaobing Wang, Hang Shi, Yongwu Liu, Jing‐hua Zhou, Zengxiang Dong, Yang Liu, Chengchuang Zhan, Yue Li, Weimin Li
Abstract
Fenofibrate inhibited atrial metabolic remodelling in AF by regulating the PPAR-α/sirtuin 1/PGC-1α pathway. The present study may provide a novel therapeutic strategy for AF.
Related Papers
- → Regulation of SIRT1 and Its Roles in Inflammation(2022)612 cited
- → Expression of sirtuins in ovarian follicles of postnatal mice(2020)9 cited
- → Neuroprotective mechanisms of SIRT1(2009)
- → Effect of caloric restriction on the expression of the Sirtuin Proteins(2012)
- → P6-003 Sirtuin-1はヒト単球のinterleukin-10制御に関与する(2014)